208 related articles for article (PubMed ID: 16890316)
1. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Gebski V; West C; Lindegaard JC; Havsteen H; Davidson SE; Hunter R; Raleigh JA; Overgaard J
Radiother Oncol; 2006 Aug; 80(2):123-31. PubMed ID: 16890316
[TBL] [Abstract][Full Text] [Related]
2. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer.
Fyles A; Milosevic M; Pintilie M; Syed A; Levin W; Manchul L; Hill RP
Radiother Oncol; 2006 Aug; 80(2):132-7. PubMed ID: 16920212
[TBL] [Abstract][Full Text] [Related]
3. The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy.
Durand RE; Aquino-Parsons C
Radiother Oncol; 2006 Aug; 80(2):138-42. PubMed ID: 16916562
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
Rofstad EK; Sundfør K; Lyng H; Tropé CG
Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
[TBL] [Abstract][Full Text] [Related]
5. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
6. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.
Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Ladekarl M; Havsteen H; Lindegaard JC; Davidson SE; Varia M; West C; Hunter R; Overgaard J; Raleigh JA
Radiother Oncol; 2003 Apr; 67(1):35-44. PubMed ID: 12758238
[TBL] [Abstract][Full Text] [Related]
7. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.
Hockel M; Schlenger K; Aral B; Mitze M; Schaffer U; Vaupel P
Cancer Res; 1996 Oct; 56(19):4509-15. PubMed ID: 8813149
[TBL] [Abstract][Full Text] [Related]
8. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix.
Höckel M; Vorndran B; Schlenger K; Baussmann E; Knapstein PG
Gynecol Oncol; 1993 Nov; 51(2):141-9. PubMed ID: 8276286
[TBL] [Abstract][Full Text] [Related]
9. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements.
Milosevic M; Fyles A; Hedley D; Pintilie M; Levin W; Manchul L; Hill R
Cancer Res; 2001 Sep; 61(17):6400-5. PubMed ID: 11522633
[TBL] [Abstract][Full Text] [Related]
10. Carbogen inhalation in cervical cancer: assessment of oxygenation change.
Aquino-Parsons C; Lim P; Green A; Minchinton AI
Gynecol Oncol; 1999 Aug; 74(2):259-64. PubMed ID: 10419742
[TBL] [Abstract][Full Text] [Related]
11. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
12. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
[TBL] [Abstract][Full Text] [Related]
14. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
Nordsmark M; Loncaster J; Chou SC; Havsteen H; Lindegaard JC; Davidson SE; Varia M; West C; Hunter R; Overgaard J; Raleigh JA
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):581-6. PubMed ID: 11173158
[TBL] [Abstract][Full Text] [Related]
15. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
[TBL] [Abstract][Full Text] [Related]
16. Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy.
Bache M; Holzapfel D; Kappler M; Holzhausen HJ; Taubert H; Dunst J; Hänsgen G
Gynecol Oncol; 2007 Jan; 104(1):139-44. PubMed ID: 16919715
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
18. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
Carnell DM; Smith RE; Daley FM; Saunders MI; Bentzen SM; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):91-9. PubMed ID: 16563659
[TBL] [Abstract][Full Text] [Related]
20. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity.
Cooper RA; West CM; Wilks DP; Logue JP; Davidson SE; Roberts SA; Hunter RD
Br J Cancer; 1999 Sep; 81(2):354-8. PubMed ID: 10496365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
